Makers of Plavix Ordered To Pay $834 Million For Misleading Marketing
A judge in Hawaii orders Bristol-Myers Squibb and Sanofi to pay the state more than $834 million for illegally marketing the blood-thinning drug Plavix.
The independent source for health policy research, polling, and news.
16,401 - 16,420 of 112,616 Results
A judge in Hawaii orders Bristol-Myers Squibb and Sanofi to pay the state more than $834 million for illegally marketing the blood-thinning drug Plavix.
The data for the 12-month period ending last June showed 81,003 deaths, a 20% increase over the previous year. Separate research found that weekly counts of all drug overdoses were up to 45% higher in 2020 than in 2019.
The new study looks at two supplements, also taken by many to fight common colds, that started disappearing from market shelves. Other news reports look at blood thinner benefits, new research centers at Tulane and more.
The long-anticipated guidance released Friday sets standards for community spread that few places in the U.S. currently fall under, disappointing many eager for school to quickly reopen in-person learning.
Federal health insurance markets opened Monday for a special three-month enrollment period due to the pandemic.
Americans can't get covid tests and N95 masks one year into the pandemic. Even hospitals have trouble finding masks. And yet they are being exported.
As new daily cases fall below the 90,000 mark, infectious disease experts explore the reasons for the drop over the last four weeks and try to predict the future trajectory of the virus.
In other vaccine news: The University of Oxford begins testing the safety of the AstraZeneca vaccine on young children; the FDA struggles to track vaccine reactions; and there's positive new data from Israel on the Pfizer vaccine.
The latest research by British scientists confirms preliminary findings that the B.1.1.7 variant of the coronavirus does cause more severe cases of covid-19 and can lead to more deaths.
Various reports from across the country as states expand and contract eligibility to get the covid vaccine. Also, stories directly from people in search of a shot.
And in other vaccine news: Pfizer assures the public it can deliver 2 billion vaccine doses; the Pentagon approves more military help to administer vaccines; and an effort to speed vaccines to nursing home residents and staff won't be completed until late next month.
Two massive storm systems knocked out power across large swaths of the U.S., driving many to emergency heating centers during the pandemic. The ice and snow also forced many vaccination sites to close.
Today's early morning highlights from the major news organizations.
Editorial pages focus on these public health issues and others.
Opinion writers weigh in on these pandemic topics and more.
Each week, KHN finds longer stories for you to sit back and enjoy. This week's selections include stories on skittish scientists, mental health professionals, eating better, how to improve the medical system and more.
The country halted its rollout of the shot when studies showed it was not effective enough against the pervasive 501Y.V2 variant. South Africa's health minister says he will consider a trade or sale. Other news is from Japan, China and Tanzania.
Other news from states across the nation touches on drug affordability, HIV, the Minnesota health clinic shooting, homelessness and more.
Women more often drive lighter, smaller cars than men. The findings suggest that car-safety researchers may need to build crash-test dummies that better account for physical differences.
Roche's intravenous drug tocilizumab reduced the need for a mechanical ventilator and shortened the length of hospitalization, Stat reports. Other pharmaceutical and biotech news is on the opioid settlement as well as a Fresenius Kabi unit, Amicus Therapeutics, Pacific Biosciences and more.
© 2026 KFF